Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Shares Outstanding (Diluted Average) (2019 - 2025)

Silo Pharma's Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $6.7 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 96.94% year-over-year to $6.7 million; the TTM value through Sep 2025 reached $6.7 million, up 96.94%, while the annual FY2024 figure was $3.7 million, 19.5% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $6.7 million at Silo Pharma, up from $6.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $96.9 million in Q2 2021 and bottomed at $1.9 million in Q4 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $3.1 million (2023), against an average of $12.5 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) crashed 97.95% in 2022 before it surged 105.71% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.9 million in 2021, then increased by 19.07% to $2.3 million in 2022, then skyrocketed by 34.83% to $3.1 million in 2023, then grew by 19.5% to $3.7 million in 2024, then surged by 82.5% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for SILO's Shares Outstanding (Diluted Average) are $6.7 million (Q3 2025), $6.3 million (Q2 2025), and $4.5 million (Q1 2025).